1. Home
  2. ENTX vs KBSX Comparison

ENTX vs KBSX Comparison

Compare ENTX & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • KBSX
  • Stock Information
  • Founded
  • ENTX 2010
  • KBSX 1976
  • Country
  • ENTX Israel
  • KBSX Taiwan
  • Employees
  • ENTX 21
  • KBSX N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • KBSX Recreational Games/Products/Toys
  • Sector
  • ENTX Health Care
  • KBSX Consumer Discretionary
  • Exchange
  • ENTX Nasdaq
  • KBSX Nasdaq
  • Market Cap
  • ENTX 91.3M
  • KBSX 74.8M
  • IPO Year
  • ENTX 2018
  • KBSX N/A
  • Fundamental
  • Price
  • ENTX $2.00
  • KBSX $1.67
  • Analyst Decision
  • ENTX Strong Buy
  • KBSX
  • Analyst Count
  • ENTX 1
  • KBSX 0
  • Target Price
  • ENTX $10.00
  • KBSX N/A
  • AVG Volume (30 Days)
  • ENTX 294.0K
  • KBSX 29.3K
  • Earning Date
  • ENTX 08-08-2025
  • KBSX 05-16-2025
  • Dividend Yield
  • ENTX N/A
  • KBSX N/A
  • EPS Growth
  • ENTX N/A
  • KBSX N/A
  • EPS
  • ENTX N/A
  • KBSX N/A
  • Revenue
  • ENTX $166,000.00
  • KBSX $36,499,644.00
  • Revenue This Year
  • ENTX N/A
  • KBSX N/A
  • Revenue Next Year
  • ENTX N/A
  • KBSX N/A
  • P/E Ratio
  • ENTX N/A
  • KBSX N/A
  • Revenue Growth
  • ENTX 191.23
  • KBSX 27.04
  • 52 Week Low
  • ENTX $1.50
  • KBSX $1.26
  • 52 Week High
  • ENTX $2.79
  • KBSX $15.48
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 54.00
  • KBSX N/A
  • Support Level
  • ENTX $1.87
  • KBSX N/A
  • Resistance Level
  • ENTX $2.14
  • KBSX N/A
  • Average True Range (ATR)
  • ENTX 0.10
  • KBSX 0.00
  • MACD
  • ENTX 0.00
  • KBSX 0.00
  • Stochastic Oscillator
  • ENTX 60.00
  • KBSX 0.00

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

Share on Social Networks: